Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update
Can J Diabetes
.
2016 Dec;40(6):484-486.
doi: 10.1016/j.jcjd.2016.09.003.
Author
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee
Collaborators
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee
:
Gillian Booth
,
Lorraine Lipscombe
,
Sonia Butalia
,
Kaberi Dasgupta
,
Dean Eurich
,
Ronald Goldenberg
,
Nadia Khan
,
Lori MacCallum
,
Baiju Shah
,
Scot Simpson
,
Robyn L Houlden
PMID:
27912867
DOI:
10.1016/j.jcjd.2016.09.003
No abstract available
MeSH terms
Diabetes Mellitus, Type 2 / drug therapy*
Disease Management
Humans
Hypoglycemic Agents / therapeutic use*
Practice Guidelines as Topic / standards*
Prognosis
Substances
Hypoglycemic Agents